<VariationArchive VariationID="185496" VariationName="NM_000143.4(FH):c.786_806del (p.Lys263_Ile269del)" VariationType="Deletion" Accession="VCV000185496" Version="16" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-07-29" DateCreated="2016-09-24" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="181631" VariationID="185496">
      <GeneList>
        <Gene Symbol="FH" FullName="fumarate hydratase" GeneID="2271" HGNC_ID="HGNC:3700" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q43</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="241497603" stop="241519755" display_start="241497603" display_stop="241519755" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="241660856" stop="241683084" display_start="241660856" display_stop="241683084" Strand="-" />
          </Location>
          <OMIM>136850</OMIM>
          <Haploinsufficiency last_evaluated="2020-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FH">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FH">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000143.4(FH):c.786_806del (p.Lys263_Ile269del)</Name>
      <CanonicalSPDI>NC_000001.11:241506100:ATTCTTGGCATGGCAGCTTTTATTCTTG:ATTCTTG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q43</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="241506101" stop="241506121" display_start="241506101" display_stop="241506121" variantLength="21" positionVCF="241506100" referenceAlleleVCF="GATTCTTGGCATGGCAGCTTTT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="241669401" stop="241669421" display_start="241669401" display_stop="241669421" variantLength="21" positionVCF="241669400" referenceAlleleVCF="GATTCTTGGCATGGCAGCTTTT" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.241669408_241669428del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.241669408_241669428del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.241506108_241506128del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.241506108_241506128del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012338.1" sequenceAccession="NG_012338" sequenceVersion="1" change="g.18634_18654del">
            <Expression>NG_012338.1:g.18634_18654del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000143.4" sequenceAccession="NM_000143" sequenceVersion="4" change="c.786_806del" MANESelect="true">
            <Expression>NM_000143.4:c.786_806del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000134.2" sequenceAccession="NP_000134" sequenceVersion="2" change="p.Lys263_Ile269del">
            <Expression>NP_000134.2:p.Lys263_Ile269del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_504" sequenceAccession="LRG_504">
            <Expression>LRG_504:g.18634_18654del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_504t1" sequenceAccession="LRG_504t1">
            <Expression>LRG_504t1:c.786_806del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_504p1" sequenceAccession="LRG_504p1" change="p.Lys263_Ile269del">
            <Expression>LRG_504p1:p.Lys263_Ile269del</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000143.3" sequenceAccession="NM_000143" sequenceVersion="3" change="c.786_806delAAAAGCTGCCATGCCAAGAAT">
            <Expression>NM_000143.3:c.786_806delAAAAGCTGCCATGCCAAGAAT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000143.3" sequenceAccession="NM_000143" sequenceVersion="3" change="c.786_806del21">
            <Expression>NM_000143.3:c.786_806del21</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA192112" DB="ClinGen" />
        <XRef Type="rs" ID="786202220" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000143.4(FH):c.786_806del (p.Lys263_Ile269del) AND Hereditary cancer-predisposing syndrome" Accession="RCV000164936" Version="12">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-01-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000143.4(FH):c.786_806del (p.Lys263_Ile269del) AND not provided" Accession="RCV001559555" Version="12">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-06-14" SubmissionCount="3">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000143.4(FH):c.786_806del (p.Lys263_Ile269del) AND Fumarase deficiency" Accession="RCV003462155" Version="1">
        <ClassifiedConditionList TraitSetID="5266">
          <ClassifiedCondition DB="MedGen" ID="C0342770">Fumarase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-01" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000143.4(FH):c.786_806del (p.Lys263_Ile269del) AND Hereditary leiomyomatosis and renal cell cancer" Accession="RCV003456005" Version="1">
        <ClassifiedConditionList TraitSetID="6363">
          <ClassifiedCondition DB="MedGen" ID="C1708350">Hereditary leiomyomatosis and renal cell cancer</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-12" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-12" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2016-09-24" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(3); Likely pathogenic(2); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">21445611</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(3); Likely pathogenic(2); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2023-12-29">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2020-03-24">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2020-03-23">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-10-10">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2017-04-16">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2016-09-23">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5266" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2154" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Fumaric aciduria</ElementValue>
                <XRef ID="MONDO:0011730" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fumarate Hydratase Deficiency</ElementValue>
                <XRef ID="NBK1506" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Fumarase deficiency</ElementValue>
                <XRef ID="Fumaric+Aciduria/2963" DB="Genetic Alliance" />
                <XRef ID="237983002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FMRD</ElementValue>
                <XRef Type="MIM" ID="606812" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Fumarate hydratase (FH) deficiency results in severe neonatal and early infantile encephalopathy that is characterized by poor feeding, failure to thrive, hypotonia, lethargy, and seizures. Dysmorphic facial features include frontal bossing, depressed nasal bridge, and widely spaced eyes. Many affected individuals are microcephalic. A spectrum of brain abnormalities are seen on magnetic resonance imaging, including cerebral atrophy, enlarged ventricles and generous extra-axial cerebral spinal fluid (CSF) spaces, delayed myelination for age, thinning of the corpus callosum, and an abnormally small brain stem. Brain malformations including bilateral polymicrogyria and absence of the corpus callosum can also be observed. Development is severely affected: most affected individuals are nonverbal and nonambulatory, and many die during early childhood. Less severely affected individuals with moderate cognitive impairment and long-term survival have been reported.</Attribute>
                <XRef ID="NBK1506" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6476" />
                <XRef ID="6476" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301679</ID>
                <ID Source="BookShelf">NBK1506</ID>
              </Citation>
              <XRef ID="24" DB="Orphanet" />
              <XRef ID="C0342770" DB="MedGen" />
              <XRef ID="MONDO:0011730" DB="MONDO" />
              <XRef Type="MIM" ID="606812" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6363" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5392" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary leiomyomatosis and renal cell cancer</ElementValue>
                <XRef ID="Leiomyomatosis+and+renal+cell+cancer%2C+hereditary/4161" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007888" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial leiomyomatosis</ElementValue>
                <XRef ID="MONDO:0023616" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MULTIPLE CUTANEOUS AND UTERINE LEIOMYOMATA 1, WITH OR WITHOUT RENAL CELL CARCINOMA</ElementValue>
                <XRef Type="MIM" ID="150800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Reed syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Multiple cutaneous and uterine leiomyomatosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cutaneous leiomyomata with uterine leiomyomata</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leiomyoma, hereditary multiple, of skin</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Multiple cutaneous and uterine leiomyomata</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leiomyoma, multiple cutaneous</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Multiple cutaneous leiomyomas</ElementValue>
                <XRef ID="HP:0007437" DB="Human Phenotype Ontology" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">LRCC</ElementValue>
                <XRef Type="MIM" ID="150800" DB="OMIM" />
                <XRef Type="MIM" ID="605839" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MCUL1</ElementValue>
                <XRef Type="MIM" ID="150800" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HLRCC</ElementValue>
                <XRef Type="MIM" ID="150800" DB="OMIM" />
                <XRef Type="MIM" ID="605839" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MCL</ElementValue>
                <XRef Type="MIM" ID="150800" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MCUL</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10096" />
                <XRef ID="10096" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">FH tumor predisposition syndrome is characterized by cutaneous leiomyomata, uterine leiomyomata (fibroids), and/or renal tumors. Pheochromocytoma and paraganglioma have also been described in a small number of families. Cutaneous leiomyomata appear as skin-colored to light brown papules or nodules distributed over the trunk and extremities, and occasionally on the face, and appear at a mean age of 30 years, increasing in size and number with age. Uterine leiomyomata tend to be numerous and large; age at diagnosis ranges from 18 to 53 years, with most women experiencing irregular or heavy menstruation and pelvic pain. Renal tumors are usually unilateral, solitary, and aggressive. They are associated with poor survival due to clinical aggressiveness and propensity to metastasize despite small primary tumor size. The median age of detection is approximately age 40 years.</Attribute>
                <XRef ID="NBK1252" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000528532" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501395" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570011" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000595970" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500895" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528534" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501538" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520030" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592450" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508575" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501539" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592488" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530028" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501397" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3218" />
                <XRef ID="3218" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301430</ID>
                <ID Source="BookShelf">NBK1252</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="KCRNC, 2013">
                <ID Source="PubMed">24319509</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Renal cell carcinoma genetics">
                <ID Source="PubMed">26389510</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, HLRCC syndrome">
                <URL>https://www.cancer.gov/types/kidney/hp/renal-cell-carcinoma-genetics/hlrcc-syndrome</URL>
                <CitationText>PDQ® Cancer Genetics Editorial Board. PDQ Hereditary Leiomyomatosis and Renal Cell Cancer. Bethesda, MD: National Cancer Institute. Updated &lt;03/08/2021&gt;. Accessed &lt;05/05/2021&gt;.</CitationText>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="523" DB="Orphanet" />
              <XRef ID="C1708350" DB="MedGen" />
              <XRef ID="MONDO:0007888" DB="MONDO" />
              <XRef Type="MIM" ID="150800" DB="OMIM" />
              <XRef Type="primary" ID="HP:0007437" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3501481" SubmissionDate="2021-08-13" DateLastUpdated="2021-08-14" DateCreated="2021-08-14">
        <ClinVarSubmissionID localKey="GDXSV:31806" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001781805" DateUpdated="2021-08-14" DateCreated="2021-08-14" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-03-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Not observed in large population cohorts (Lek et al., 2016); In-frame deletion of 7 amino acids in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FH" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:2095496</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000143.3:c.786_806delAAAAGCTGCCATGCCAAGAAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_22_20210812085049</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7844835" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000143.4:c.786_806del|OMIM:606812" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004197357" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000143.4:c.786_806del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="606812" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="386624" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2015-03-24">
        <ClinVarSubmissionID localKey="a94325|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000215625" DateUpdated="2024-05-01" DateCreated="2015-03-24" Type="SCV" Version="8" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.786_806del21 pathogenic mutation (also known as p.I262_R268del) is located in coding exon 6 of the FH gene. This variant results from an in-frame deletion of 21 nucleotides from positions 786 to 806. This results in the deletion of 7 amino acid residues from codons 262 to 268. The exact functional impact of these amino acids is unknown at this time; however, internal structural analysis suggests the I262_R268del alteration results in a distortion of the alpha-helix of the protein-protein interface, significantly altering the surrounding residues (Kavanagh KL et al. Crystal structure of human fumarate hydratase. Structural Genomics Consortium. Protein Data Bank, accessed 10/13/2015. DOI:10.2210/pdb3e04/pdb). This alteration has been detected in multiple individuals who have a personal or family history that is consistent or suggestive of HLRCC (Ambry internal data). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). These amino acid positions are well conserved on available sequence alignment. In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FH" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000143.3:c.786_806del21</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7825510" SubmissionDate="2023-12-21" DateLastUpdated="2023-12-24" DateCreated="2023-12-24">
        <ClinVarSubmissionID localKey="101976491|OMIM:150800" />
        <ClinVarAccession Accession="SCV004186944" DateUpdated="2023-12-24" DateCreated="2023-12-24" Type="SCV" Version="1" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>This variant is considered likely pathogenic. This variant has been reported in multiple individuals with clinical features of gene-specific disease. This variant is expected to disrupt protein structure [Myriad internal data].</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/8ufcwsf2/myriad_genetics_classification_criteria_2023.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FH" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="1" alternateAllele="G" referenceAllele="GATTCTTGGCATGGCAGCTTTT" start="241669400" stop="241669421" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">101976491</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="150800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14104645</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7887621" SubmissionDate="2023-12-22" DateLastUpdated="2024-01-06" DateCreated="2024-01-06">
        <ClinVarSubmissionID localKey="S12924|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004218898" DateUpdated="2024-01-06" DateCreated="2024-01-06" Type="SCV" Version="1" SubmitterName="Quest Diagnostics Nichols Institute San Juan Capistrano" OrgID="500110" OrganizationCategory="laboratory" OrgAbbreviation="Quest Diagnostics" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21445611</ID>
          </Citation>
          <Comment>The FH c.786_806del (p.Lys263_Ile269del) variant has been reported in individuals with hereditary leiomyomatosis and renal cell cancer (HLRCC). There are no published functional effects of this variant. However, structural analysis revealed that this variant may be present in a region critical to protein function and results in a disruption of nearby residues (PMID: 21445611 (2011)). This variant has not been reported in large, multi-ethnic general populations (Genome Aggregation Database, http://gnomad.broadinstitute.org). Based on the available information, this variant is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Quest Diagnostics criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000143.3:c.786_806del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14108248</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1057198" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2017-04-17">
        <ClinVarSubmissionID localKey="122686|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000544279" DateUpdated="2024-02-28" DateCreated="2017-04-17" Type="SCV" Version="9" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 185496). This variant has been observed in individuals with hereditary leiomyomatosis and renal cell cancer (HLRCC) (Invitae). This variant is not present in population databases (gnomAD no frequency). This variant, c.786_806del, results in the deletion of 7 amino acid(s) of the FH protein (p.Lys263_Ile269del), but otherwise preserves the integrity of the reading frame.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FH" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.241669401_241669421del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3501481" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7844835" TraitType="Disease" MappingType="XRef" MappingValue="606812" MappingRef="OMIM">
        <MedGen CUI="C0342770" Name="Fumarase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7887621" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7825510" TraitType="Disease" MappingType="XRef" MappingValue="150800" MappingRef="OMIM">
        <MedGen CUI="C1708350" Name="Hereditary leiomyomatosis and renal cell cancer" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1057198" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="386624" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

